Serotonergic neurons are involved in the counter-regulatory response to hypoglycemia

J Neuroendocrinol. 2023 Dec;35(12):e13344. doi: 10.1111/jne.13344. Epub 2023 Oct 19.

Abstract

Objectives: Intensive insulin therapy provides optimal glycemic control in patients with diabetes. However, intensive insulin therapy causes so-called iatrogenic hypoglycemia as a major adverse effect. The ventromedial hypothalamus (VMH) has been described as the primary brain area initiating the counter-regulatory response (CRR). Nevertheless, the VMH receives projections from other brain areas which could participate in the regulation of the CRR. In particular, studies suggest a potential role of the serotonin (5-HT) network. Thus, the objective of this study was to determine the contribution of 5-HT neurons in CRR control.

Methods: Complementary approaches have been used to test this hypothesis in quantifying the level of 5-HT in several brain areas by HPLC in response to insulin-induced hypoglycemia, measuring the electrical activity of dorsal raphe (DR) 5-HT neurons in response to insulin or decreased glucose level by patch-clamp electrophysiology; and measuring the CRR hormone glucagon as an index of the CRR to the modulation of the activity of 5-HT neurons using pharmacological or pharmacogenetic approaches.

Results: HPLC measurements show that the 5HIAA/5HT ratio is increased in several brain regions including the VMH in response to insulin-induced hypoglycemia. Patch-clamp electrophysiological recordings show that insulin, but not decreased glucose level, increases the firing frequency of DR 5-HT neurons in the DR. In vivo, both the pharmacological inhibition of 5-HT neurons by intraperitoneal injection of the 5-HT1A receptor agonist 8-OH-DPAT or the chemogenetic inhibition of these neurons reduce glucagon secretion, suggesting an impaired CRR.

Conclusion: Taken together, these data highlight a new neuronal network involved in the regulation of the CRR. In particular, this study shows that DR 5-HT neurons detect iatrogenic hypoglycemia in response to the increased insulin level and may play an important role in the regulation of CRR.

Keywords: chemogenetic; glucagon; hypoglycemia; insulin; serotonin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glucagon*
  • Glucose
  • Humans
  • Hypoglycemia* / chemically induced
  • Iatrogenic Disease
  • Insulin / pharmacology
  • Serotonergic Neurons
  • Serotonin / pharmacology

Substances

  • Glucagon
  • Serotonin
  • Insulin
  • Glucose